To locate the upstream pathways that are responsible for the upregulation of CD47 through the binding and activation of distal cis-regulatory regions, we focused first on finding candidate transcription factors that bind to the breast cancer specific constituent, E5. The gene discussed is CD47; the disease is breast carcinoma.